Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments have been game-changers for lung cancer and skin cancer, prostate cancer ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

The average age of men who get diagnosed is 67.

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

Men with prostate cancer who were treated with the GnRH agonist leuprolide had significantly more coronary artery plaque progression than those receiving the GnRH antagonist relugolix.

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...

Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer and found “small fragments of plastic” in both — but the tumors had much higher ...